Yasmin Karimi, Pau Abrisqueta, Charalambos Andreadis, Chan Cheah, Justin Darrah, Sven de Vos, Lorenzo Falchi, Gerardo Musuraca, Marek Trneny, Anna Sureda, Charles Kearns, Kimberly G. Archer, Milan Geybels, Malene Risum, Jon Ukropec, Mohammad E. Atiya, Raúl Córdoba. "Epcoritamab (epcor) + chemoimmunotherapy (CIT) in patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL) eligible for autologous stem cell transplant (ASCT): Pooled results from arms 4 and 10 of EPCORE NHL-2.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7061